Keywords: fda, delays, nda, reviews, despite, budget, rise

FDA delays NDA reviews despite budget rise

Article | 03 November 2008

Print This

The US Food and Drug Administration has delayed 15 New Drug Applications under the Prescription Drug User Fee Act, despite payments ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in